Related references
Note: Only part of the references are listed.Socioeconomic disadvantage and the risk of advanced chronic kidney disease: results from a cohort study with 1.4 million participants
Misghina Weldegiorgis et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)
Serum Lipids and Risk of Rapid Renal Function Decline in Treated Hypertensive Adults With Normal Renal Function
Xianglin Zhang et al.
AMERICAN JOURNAL OF HYPERTENSION (2019)
HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study
Matthew B. Lanktree et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Adeera Levin et al.
LANCET (2017)
Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England
William G. Herrington et al.
PLOS ONE (2017)
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative
Giuseppina T. Russo et al.
DIABETES CARE (2016)
Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression
Benjamin Bowe et al.
KIDNEY INTERNATIONAL (2016)
Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population
Kazuhiko Tsuruya et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Emily Herrett et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Relation of Serum Lipids and Lipoproteins with Progression of CKD: The CRIC Study
Mahboob Rahman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Triglycerides and cardiovascular disease
Borge G. Nordestgaard et al.
LANCET (2014)
HDL and cardiovascular disease
Daniel J. Rader et al.
LANCET (2014)
LDL cholesterol: controversies and future therapeutic directions
Paul M. Ridker
LANCET (2014)
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people
Eleni Rapsomaniki et al.
LANCET (2014)
Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation
Anette Varbo et al.
CIRCULATION (2013)
High-density lipoproteins: A consensus statement from the National Lipid Association
Peter P. Toth et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2013)
Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy Results of the ADVANCE study
Jamie Morton et al.
DIABETES CARE (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis
George Thomas et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Hyperlipidemia and Long-Term Outcomes in Nondiabetic Chronic Kidney Disease
Varun Chawla et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
Brian G. Drew et al.
CIRCULATION (2009)
High-density lipoproteins, inflammation and oxidative stress
Fatiha Tabet et al.
CLINICAL SCIENCE (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Predictors of new-onset decline in kidney function in a general middle-european population
Rudolf P. Obermayr et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Predictors of new-onset kidney disease in a community-based population
CS Fox et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria
M Tozawa et al.
KIDNEY INTERNATIONAL (2002)
Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study
P Muntner et al.
KIDNEY INTERNATIONAL (2000)
Estrogen effects on triglyceride metabolism in analbuminemic rats
GC Shearer et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
